| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BANDROWCZAK STEVEN JOHN | CEO, Director | XEROX HOLDINGS CORPORATION, P.O. BOX 4505 401 MERRITT 7, NORWALK | /s/ Eric Risi, as attorney-in-fact | 05 Aug 2025 | 0001407036 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XRX | Restricted Stock Unit | Options Exercise | $0 | -60,071 | -5.1% | $0.000000 | 1,113,300 | 02 Aug 2025 | Direct | F1 |
| transaction | XRX | Common Stock | Options Exercise | +60,071 | +16% | 442,513 | 02 Aug 2025 | Direct | F1, F2 | ||
| transaction | XRX | Common Stock | Tax liability | $109,678 | -27,837 | -6.3% | $3.94 | 414,676 | 02 Aug 2025 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On August 2, 2022, the reporting person was granted an award of 176,679 Restricted Stock Units, which vests in three installments of 33%, 33% and 34% on the first, second and third anniversaries of the grant date. |
| F2 | Restricted Stock Units convert into common stock on a one-for-one basis. |
| F3 | Of the 60,071 Restricted Stock Units that vested, 27,837 were withheld and disposed of for taxes. |